• Nabriva Therapeutics (NASDAQ:NBRV) vs. Generex Biotechnology (OTCMKTS:GNBT) Head to Head Survey Defense World Mon, 25 Aug 2025 07:00:00 GMT
• fda approves xenleta for community-acquired bacterial pneumonia Pharmaceutical Technology Tue, 19 Aug 2025 07:00:00 GMT
• osteomyelitis clinical and non-clinical studies, key companies, therapeutic assessment, emerging therapies, treatment algorithm, a... Barchart.com Mon, 23 Jun 2025 21:48:17 GMT
• nabriva therapeutics to present at the h.c. wainwright global investment conference Barchart.com Wed, 18 Jun 2025 15:54:00 GMT
• nabriva extends exclusive agreement to promote and distribute sivextro® (tedizolid phosphate) in the u.s. through the end of 2026 Barchart.com Thu, 12 Jun 2025 16:27:00 GMT
• nabriva therapeutics to present at the h.c. wainwright global investment conference Barchart.com Thu, 12 Jun 2025 16:27:00 GMT
• today's research reports on stocks to watch: itus corporation and nabriva therapeutics ACCESS Newswire Tue, 03 Jun 2025 03:47:37 GMT
• nabriva therapeutics (nasdaq:nbrv) now covered by analysts at stocknews.com Defense World Thu, 22 May 2025 08:16:09 GMT
• nabriva therapeutics (nasdaq:nbrv) now covered by stocknews.com Defense World Wed, 14 May 2025 07:00:00 GMT
• nabriva therapeutics (nasdaq:nbrv) coverage initiated by analysts at stocknews.com Defense World Tue, 06 May 2025 22:09:52 GMT
• nabriva therapeutics (nasdaq:nbrv) earns hold rating from analysts at stocknews.com Defense World Mon, 28 Apr 2025 07:00:00 GMT
• nabriva therapeutics (nasdaq:nbrv) coverage initiated by analysts at stocknews.com American Banking and Market News Mon, 28 Apr 2025 06:08:48 GMT
• nabriva therapeutics (nasdaq:nbrv) earns hold rating from analysts at stocknews.com Defense World Sun, 20 Apr 2025 06:34:36 GMT
• phathom pharmaceuticals appoints ted schroeder to its board of directors GlobeNewswire Wed, 16 Apr 2025 07:00:00 GMT
• stocknews.com initiates coverage on nabriva therapeutics (nasdaq:nbrv) Defense World Sat, 12 Apr 2025 07:00:00 GMT
• nabriva therapeutics (nasdaq:nbrv) coverage initiated at stocknews.com Defense World Fri, 04 Apr 2025 07:00:00 GMT
• nabriva therapeutics (nasdaq:nbrv) coverage initiated at stocknews.com The AM Reporter Thu, 27 Mar 2025 07:00:00 GMT
• nabriva therapeutics (nasdaq:nbrv) now covered by analysts at stocknews.com The AM Reporter Wed, 19 Mar 2025 07:00:00 GMT
• nabriva therapeutics (nasdaq:nbrv) now covered by stocknews.com Defense World Tue, 11 Mar 2025 09:16:17 GMT
• nabriva therapeutics (nasdaq:nbrv) earns hold rating from analysts at stocknews.com Defense World Mon, 03 Mar 2025 07:20:23 GMT
• nabriva therapeutics (nasdaq:nbrv) coverage initiated at stocknews.com Defense World Sun, 23 Feb 2025 08:00:00 GMT
• stocknews.com initiates coverage on nabriva therapeutics (nasdaq:nbrv) Armenian Reporter Mon, 17 Feb 2025 08:00:00 GMT
• nabriva therapeutics (nasdaq:nbrv) coverage initiated by analysts at stocknews.com Defense World Sat, 15 Feb 2025 08:00:00 GMT
• nabriva therapeutics (nasdaq:nbrv) research coverage started at stocknews.com Defense World Mon, 10 Feb 2025 08:00:00 GMT
• nabriva therapeutics (nasdaq:nbrv) coverage initiated at stocknews.com Defense World Thu, 30 Jan 2025 07:13:38 GMT
• nabriva therapeutics (nasdaq:nbrv) now covered by analysts at stocknews.com Defense World Wed, 22 Jan 2025 08:00:00 GMT
• nabriva therapeutics (nasdaq:nbrv) now covered by analysts at stocknews.com Defense World Tue, 14 Jan 2025 08:00:00 GMT
• nabriva therapeutics (nasdaq:nbrv) now covered by analysts at stocknews.com Defense World Mon, 06 Jan 2025 07:26:36 GMT
• nabriva therapeutics (nasdaq:nbrv) earns hold rating from analysts at stocknews.com Defense World Sun, 29 Dec 2024 08:00:00 GMT
• stocknews.com initiates coverage on nabriva therapeutics (nasdaq:nbrv) Defense World Sat, 21 Dec 2024 08:00:00 GMT
• Meitheal secures exclusive commercial rights to Xenleta in US World Pharmaceutical Frontiers Thu, 12 Dec 2024 08:00:00 GMT
• meitheal gains us commercial rights for cabp treatment therapy Pharmaceutical Technology Thu, 12 Dec 2024 08:00:00 GMT
• Meitheal Pharmaceuticals Grows Specialty Biopharmaceuticals Portfolio with Exclusive Commercial Licensing Agreement for XENLETA® (... Business Wire Wed, 11 Dec 2024 08:00:00 GMT
• stocknews.com initiates coverage on nabriva therapeutics (nasdaq:nbrv) Defense World Thu, 05 Dec 2024 08:00:00 GMT
• nabriva therapeutics (nasdaq:nbrv) coverage initiated at stocknews.com Defense World Wed, 27 Nov 2024 08:42:20 GMT
• nabriva therapeutics (nasdaq:nbrv) coverage initiated by analysts at stocknews.com Defense World Mon, 11 Nov 2024 07:44:20 GMT
• nabriva therapeutics (nasdaq:nbrv) coverage initiated at stocknews.com Defense World Sun, 03 Nov 2024 06:13:40 GMT
• nabriva therapeutics (nasdaq:nbrv) receives new coverage from analysts at stocknews.com Defense World Sat, 26 Oct 2024 06:36:35 GMT
• nabriva therapeutics (nasdaq:nbrv) research coverage started at stocknews.com Defense World Fri, 18 Oct 2024 06:26:43 GMT
• pleuromutilin market to witness huge growth by 2034 -shanxi xinyuan huakang, hubei chenxin pharmaceutical, nabriva, pfiz – indiapo... IndiaPolitics.com Mon, 14 Oct 2024 08:49:21 GMT
• lefamulin market 2024 by keyplayers and vendors: nabriva therapeutics, sumitomo pharma, sinovant sciences IndiaPolitics.com Mon, 14 Oct 2024 08:49:21 GMT
• nabriva therapeutics (nasdaq:nbrv) receives new coverage from analysts at stocknews.com Defense World Thu, 10 Oct 2024 09:31:20 GMT
• osteomyelitis treatment market 2031 growth drivers along with top players- vyome biosciences pvt ltd, nabriva therapeutics ag, mot... Cineglit Mon, 07 Oct 2024 07:06:23 GMT
• nabriva therapeutics (nasdaq:nbrv) now covered by stocknews.com Defense World Wed, 02 Oct 2024 08:26:55 GMT
• nabriva therapeutics (nasdaq:nbrv) now covered by analysts at stocknews.com Defense World Tue, 24 Sep 2024 07:51:45 GMT
• stocknews.com initiates coverage on nabriva therapeutics (nasdaq:nbrv) Defense World Mon, 16 Sep 2024 06:21:07 GMT
• nabriva therapeutics (nasdaq:nbrv) coverage initiated at stocknews.com Defense World Sun, 08 Sep 2024 06:11:50 GMT
• stocknews.com initiates coverage on nabriva therapeutics (nasdaq:nbrv) Defense World Sat, 31 Aug 2024 06:51:49 GMT
• nabriva therapeutics (nasdaq:nbrv) coverage initiated by analysts at stocknews.com Defense World Fri, 23 Aug 2024 06:43:56 GMT
• fda approves xenleta for community-acquired bacterial pneumonia Pharmaceutical Technology Mon, 19 Aug 2024 07:00:00 GMT
• nabriva therapeutics (nasdaq:nbrv) coverage initiated at stocknews.com Defense World Thu, 15 Aug 2024 09:24:17 GMT
• nabriva therapeutics (nasdaq:nbrv) coverage initiated by analysts at stocknews.com Defense World Wed, 07 Aug 2024 05:46:39 GMT
• nabriva therapeutics (nasdaq:nbrv) research coverage started at stocknews.com Defense World Tue, 30 Jul 2024 05:29:03 GMT
• deal watch: bi acquires nerio for novel immune checkpoint inhibitor Citeline Mon, 29 Jul 2024 07:00:00 GMT
• Meitheal Pharmaceuticals acquires Contepo from Nabriva Therapeutics Drug Store News Thu, 25 Jul 2024 07:00:00 GMT
• Meitheal acquires Contepo from Nabriva Therapeutics to expand specialty biopharmaceuticals portfolio Indian Pharma Post Tue, 23 Jul 2024 07:00:00 GMT
• meitheal pharmaceuticals expands specialty biopharmaceuticals portfolio with acquisition of contepo™ (fosfomycin for injection) fr... Elk Valley Times Mon, 22 Jul 2024 17:16:30 GMT
• meitheal acquires contepo rights from nabriva in north america World Pharmaceutical Frontiers Mon, 22 Jul 2024 07:00:00 GMT
• FDA rejects approval of Nabriva's antibiotic Contepo for complicated urinary tract infections FirstWord Pharma Fri, 19 Jul 2024 10:19:18 GMT
• Meitheal acquires rights to CONTEPO from Nabriva Pharmaceutical Technology Fri, 19 Jul 2024 07:00:00 GMT
• Meitheal taps Nabriva’s antibiotic Contepo, hoping third time lucky with the FDA FirstWord Pharma Fri, 19 Jul 2024 07:00:00 GMT
• meitheal gains rights to contepo from nabriva in north america Yahoo Finance Fri, 19 Jul 2024 07:00:00 GMT
• Meitheal Pharmaceuticals Expands Specialty Biopharmaceuticals Portfolio with Acquisition of CONTEPO™ (Fosfomycin for Injection) fr... Business Wire Thu, 18 Jul 2024 07:00:00 GMT
• nabriva therapeutics (nasdaq:nbrv) coverage initiated by analysts at stocknews.com American Banking and Market News Mon, 15 Jul 2024 07:00:00 GMT
• nabriva therapeutics (nasdaq:nbrv) now covered by analysts at stocknews.com Defense World Sun, 14 Jul 2024 05:20:27 GMT
• nabriva therapeutics (nasdaq:nbrv) coverage initiated at stocknews.com Defense World Sat, 06 Jul 2024 05:29:49 GMT
• absssi pipeline update 2024: fda approvals, therapeutic advancements, and clinical trials by delveinsight | merck & co. inc., endo... Barchart Wed, 03 Jul 2024 14:06:00 GMT
• nabriva therapeutics to present data at chest annual meeting 2021 Quantisnow Sat, 29 Jun 2024 04:59:11 GMT
• nabriva therapeutics expands xenleta® (lefamulin) presence with exclusive agreement with er-kim pharmaceuticals Quantisnow Sat, 29 Jun 2024 04:58:47 GMT
• nabriva therapeutics (nasdaq:nbrv) research coverage started at stocknews.com Defense World Fri, 28 Jun 2024 05:26:10 GMT
• nabriva's shares march higher, can it continue? Yahoo Canada Shine On Thu, 27 Jun 2024 15:32:33 GMT
• nabriva therapeutics (nasdaq:nbrv) vs. scpharmaceuticals (nasdaq:scph) financial review Defense World Wed, 26 Jun 2024 10:29:15 GMT
• stocknews.com begins coverage on nabriva therapeutics (nasdaq:nbrv) Defense World Thu, 20 Jun 2024 05:25:47 GMT
• nabriva therapeutics receives complete response letter from fda on nda for contepo for injection Reuters Wed, 19 Jun 2024 07:00:00 GMT
• nabriva therapeutics (nbrv) catches eye: stock gains 9.8% Yahoo Sport Australia Fri, 14 Jun 2024 03:35:24 GMT
• nabriva therapeutics (nbrv) catches eye: stock gains 9.8% Yahoo Sport Australia Wed, 12 Jun 2024 09:37:07 GMT
• acanthamoeba keratitis market forecast 2032: fda, ema and pdma approvals, epidemiology, therapies, companies by delveinsight The Globe and Mail Mon, 10 Jun 2024 07:00:00 GMT
• nabriva therapeutics (nasdaq:nbrv) now covered by stocknews.com Defense World Tue, 04 Jun 2024 05:31:45 GMT
• why nabriva therapeutics (nbrv) stock might be a great pick Yahoo Movies UK Mon, 27 May 2024 10:57:43 GMT
• nabriva therapeutics (nasdaq:nbrv) receives new coverage from analysts at stocknews.com Defense World Mon, 27 May 2024 05:25:38 GMT
• why nabriva therapeutics (nbrv) stock might be a great pick Yahoo Movies UK Sun, 26 May 2024 03:44:19 GMT
• nabriva therapeutics (nasdaq:nbrv) research coverage started at stocknews.com Defense World Sun, 19 May 2024 07:50:46 GMT
• nabriva therapeutics (nasdaq:nbrv) research coverage started at stocknews.com Defense World Sat, 11 May 2024 07:11:52 GMT
• uniqure (qure) moves 5% higher: will this strength last? Yahoo News UK Sun, 05 May 2024 15:12:44 GMT
• down 25.5% in 4 weeks, here's why you should you buy the dip in nabriva therapeutics ag (nbrv) Yahoo News UK Sun, 05 May 2024 11:33:44 GMT
• nabriva therapeutics (nasdaq:nbrv) research coverage started at stocknews.com Defense World Fri, 03 May 2024 06:30:15 GMT
• multidrug resistant bacteria treatment market [top players ] nabriva therapeutics, bioversys, johnson & johnson ... Motions Online Tue, 30 Apr 2024 06:36:16 GMT
• prosthetic joint infections treatment market to see incredible growth 2024-2031 |cempra inc, motif bio plc, nabriva ... Amoré Mon, 29 Apr 2024 16:44:15 GMT
• nabriva therapeutics (nasdaq:nbrv) earns hold rating from analysts at stocknews.com Defense World Thu, 25 Apr 2024 06:22:20 GMT
• nabriva (nbrv) looks good: stock adds 5.7% in session Yahoo Movies Canada Sun, 21 Apr 2024 20:58:49 GMT
• nabriva therapeutics (nasdaq:nbrv) coverage initiated by analysts at stocknews.com Defense World Wed, 17 Apr 2024 06:47:50 GMT
• contrasting cassava sciences (nasdaq:sava) & nabriva therapeutics (nasdaq:nbrv) Defense World Mon, 15 Apr 2024 07:00:00 GMT
• nabriva therapeutics (nasdaq:nbrv) research coverage started at stocknews.com Defense World Tue, 09 Apr 2024 06:23:44 GMT
• nabriva soars on agreement with merck to distribute sivextro Yahoo Movies UK Tue, 02 Apr 2024 14:44:51 GMT
• nabriva therapeutics (nasdaq:nbrv) earns hold rating from analysts at stocknews.com Defense World Mon, 01 Apr 2024 06:27:08 GMT
• nabriva therapeutics (nasdaq:nbrv) coverage initiated at stocknews.com Defense World Sun, 24 Mar 2024 06:14:17 GMT
• multidrug resistant bacteria treatment market [top players ] nabriva therapeutics, bioversys, johnson & johnson Amoré Tue, 19 Mar 2024 11:39:32 GMT
• bacterial pneumonia therapeutics industry [swot analysis]| astrazeneca, nabriva therapeutics, setlance, merck Amoré Mon, 18 Mar 2024 22:02:30 GMT
• nabriva therapeutics (nasdaq:nbrv) earns hold rating from analysts at stocknews.com Defense World Sat, 16 Mar 2024 07:00:00 GMT
• nabriva therapeutics (nasdaq:nbrv) research coverage started at stocknews.com Defense World Fri, 08 Mar 2024 08:00:00 GMT
• stocknews.com begins coverage on nabriva therapeutics (nasdaq:nbrv) American Banking News Fri, 08 Mar 2024 07:25:01 GMT
• FDA again rejects Nabriva's antibiotic Contepo to treat complicated urinary tract infections FirstWord Pharma Mon, 04 Mar 2024 05:40:58 GMT
• stocknews.com initiates coverage on nabriva therapeutics (nasdaq:nbrv) Defense World Thu, 29 Feb 2024 08:14:38 GMT
• nabriva therapeutics (nasdaq:nbrv) coverage initiated by analysts at stocknews.com American Banking News Thu, 29 Feb 2024 08:00:00 GMT
• [key companies] prosthetic joint infections treatment market | cempra inc, motif bio plc, nabriva therapeutics ag ... Amoré Thu, 29 Feb 2024 07:15:31 GMT
• complicated urinary tract infections (cutis) market poised for extraordinary growth during the forecast period (2023 ... openPR Wed, 28 Feb 2024 13:48:00 GMT
• nabriva therapeutics (nasdaq:nbrv) receives new coverage from analysts at stocknews.com Defense World Wed, 21 Feb 2024 07:20:14 GMT
• nabriva therapeutics (nasdaq:nbrv) research coverage started at stocknews.com Defense World Tue, 13 Feb 2024 06:47:59 GMT
• nabriva therapeutics (nasdaq:nbrv) receives new coverage from analysts at stocknews.com Defense World Mon, 05 Feb 2024 06:29:53 GMT
• complicated urinary tract infections treatment market development status 2029 | wockhardt, venatorx ... The Nelson Post Fri, 02 Feb 2024 04:14:19 GMT
• nabriva's pneumonia drug meets main goal in late-stage study Reuters Sat, 27 Jan 2024 00:05:11 GMT
• prosthetic joint infections treatment market 2030 growth drivers along with top players: cempra inc, motif bio plc ... The Nelson Post Tue, 23 Jan 2024 12:13:31 GMT
• community acquired bacterial pneumonia (cabp) therapeutics market to see incredible growth 2024-2031 |nabriva ... Amoré Fri, 19 Jan 2024 06:16:44 GMT
• complicated urinary tract infections treatment market developments 2030 |spero therapeutics, wockhardt, venatorx ... Future of Media Mon, 15 Jan 2024 05:58:38 GMT
• multidrug resistant bacteria treatment market research report 2030, growth trends and competition |nabriva ... Future of Media Sun, 14 Jan 2024 11:53:00 GMT
• community acquired bacterial pneumonia(cabp) therapeutics market growth report |nabriva therapeutics, melinta ... Future of Media Thu, 11 Jan 2024 17:28:09 GMT
• nabriva therapeutics (nasdaq:nbrv) coverage initiated at stocknews.com Defense World Thu, 04 Jan 2024 06:26:06 GMT
• nabriva therapeutics (nasdaq:nbrv) coverage initiated at stocknews.com Defense World Wed, 27 Dec 2023 06:19:36 GMT
• nabriva therapeutics plc files patent for fosfomycin dosing regimen Pharmaceutical Technology Fri, 22 Dec 2023 08:00:00 GMT
• nabriva therapeutics (nasdaq:nbrv) now covered by analysts at stocknews.com Defense World Wed, 20 Dec 2023 08:39:15 GMT
• multidrug resistant bacteria treatment market statistical forecast, trade analysis 2023 –nabriva therapeutics ... Artrocker Tue, 12 Dec 2023 21:32:09 GMT
• nabriva therapeutics (nasdaq:nbrv) coverage initiated by analysts at stocknews.com Defense World Tue, 12 Dec 2023 08:00:00 GMT
• complicated urinary tract infections treatment market – a ... Artrocker Tue, 05 Dec 2023 13:20:43 GMT
• alzheon promotes glenn e. pauly to chief commercial officer and ... Business Wire Tue, 05 Dec 2023 11:00:00 GMT
• global mrsa drugs market size, spotlight on future potentials ... Artrocker Mon, 04 Dec 2023 19:32:39 GMT
• ventilator associated pneumonia vap therapeutics market ... Artrocker Mon, 04 Dec 2023 12:12:24 GMT
• community-acquired bacterial pneumonia â (cabp) treatment drugs market 2023-2030: top manufactures, market ... Digital Journal Mon, 04 Dec 2023 10:47:56 GMT
• nabriva therapeutics announces completion of enrollment in leap 2, a phase 3 clinical trial evaluating oral lefamulin Reuters Mon, 04 Dec 2023 08:00:00 GMT
• der markt für medizinische instrumentensets wird 2023-2029 neue ... Rock News Mon, 04 Dec 2023 07:54:31 GMT
• markt für osteomyelitis-behandlung: trends, chancen, wachstum ... Rock News Mon, 04 Dec 2023 07:54:23 GMT
• gestenerkennung und berührungslose wahrnehmung marktdaten ... Rock News Mon, 04 Dec 2023 07:54:18 GMT
• community acquired bacterial pneumonia(cabp) therapeutics ... salisburyandstonehenge Sun, 03 Dec 2023 13:59:50 GMT
• nabriva therapeutics (nasdaq:nbrv) earns hold rating from analysts at stocknews.com Defense World Sun, 03 Dec 2023 08:00:00 GMT
• methicillin-resistant staphylococcus aureus (mrsa) market is driven by increasing demand for effective treatme openPR Fri, 01 Dec 2023 03:18:00 GMT
• a detailed report on prosthetic joint infections treatment market. size, share, trends, key insights. major pl openPR Wed, 29 Nov 2023 12:58:00 GMT
• nabriva therapeutics (nasdaq:nbrv) coverage initiated by ... Defense World Sat, 25 Nov 2023 08:26:30 GMT
• bacterial pneumonia therapeutics market growing massively by astrazeneca, nabriva therapeutics, setlance, merck ... Argyle Report Thu, 23 Nov 2023 06:08:27 GMT
• senisca strengthens board with the appointment of dr. david ... Yahoo Finance Mon, 13 Nov 2023 08:00:00 GMT
• new drug to treat community-acquired pneumonia fast tracked by fda respiratory-therapy.com Fri, 10 Nov 2023 13:17:22 GMT
• antibiotic resistance market – industry trends and forecast to 2030 | macrolide pharmaceuticals, ampliphi ... Argyle Report Mon, 06 Nov 2023 17:53:16 GMT
• marché du traitement de l'ostéomyélite par produit, utilisateur final ... Bigouden.Tv Sat, 04 Nov 2023 11:18:24 GMT
• sumitomo pharma : oct. 31, 2023 conference on q2 fy2023 ... Marketscreener.com Tue, 31 Oct 2023 07:00:00 GMT
• complicated urinary tract infection treatment market, as stated by ... PharmiWeb.com Tue, 31 Oct 2023 07:00:00 GMT
• resurgence of sars-cov-2 delta after omicron variant ... Virology Journal Fri, 27 Oct 2023 07:00:00 GMT
• the world needs new antibiotics. the problem is, no one can make them profitably. - wsj The Wall Street Journal Tue, 26 Sep 2023 07:00:00 GMT
• le monde a besoin de nouveaux antibiotiques, mais leur business ... L'Opinion Tue, 26 Sep 2023 07:00:00 GMT
• por que não estão sendo desenvolvidos novos antibióticos? Olhar Digital Tue, 26 Sep 2023 07:00:00 GMT
• methicillin-resistant staphylococcus aureus (mrsa) drugs global ... GlobeNewswire Mon, 11 Sep 2023 07:00:00 GMT
• philadelphia-area life sciences firms have now cut more than 500 jobs since the start of 2022 The Business Journals Thu, 07 Sep 2023 07:00:00 GMT
• methicillin-resistant staphylococcus aureus (mrsa) drugs global market report 2023 Yahoo Finance Thu, 24 Aug 2023 07:00:00 GMT
• nabriva therapeutics (otcpk:nbrv.f) - stock price, news & analysis Simply Wall St Wed, 02 Aug 2023 03:51:15 GMT
• sumitomo pharma : jul. 31, 2023 conference on q1 fy2023 ... Marketscreener.com Mon, 31 Jul 2023 07:00:00 GMT
• filings signal: top gainers versus losers for q2 2023 Clinical Trials Arena Wed, 19 Jul 2023 07:00:00 GMT
• determination of mic quality control ranges for ceftibuten ... American Society for Microbiology Mon, 03 Jul 2023 07:00:00 GMT
• gene therapy developer swanbio to narrow research focus, lay off half its workforce The Business Journals Thu, 29 Jun 2023 07:00:00 GMT
• sepsis market size and share to grow by 2032, examines ... Yahoo Finance Thu, 29 Jun 2023 07:00:00 GMT
• complicated urinary tract infection market size was usd ~1800 ... Medgadget Tue, 27 Jun 2023 07:00:00 GMT
• complicated urinary tract infection (cuti) market to witness growth by 2032, estimates delveinsight| meiji seika pharma, pfizer, n... Financial Content Fri, 16 Jun 2023 07:00:00 GMT
• nabriva therapeutics to present data at asm microbe supporting ongoing phase 3 clinical development program for ... Reuters Fri, 02 Jun 2023 07:00:00 GMT
• clarametyx biosciences announces changes to its scientific ... Business Wire Tue, 30 May 2023 07:00:00 GMT
• nabriva therapeutics plc management's discussion and analysis of financial condition and results of operations (form 10-k) MarketScreener Mon, 17 Apr 2023 07:00:00 GMT
• sumitomo pharma subsidiary companies in the u.s. ... Marketscreener.com Tue, 04 Apr 2023 07:00:00 GMT
• 5 biotech and pharma companies in new jersey you oughta know BioBuzz Tue, 21 Feb 2023 21:03:02 GMT
• nbrv stock on watch as merck ends distribution agreement (nasdaq:nbrv) Seeking Alpha Mon, 06 Feb 2023 08:00:00 GMT
• cash-strapped calithera closes down in shadow of enrollment ... FierceBiotech Tue, 10 Jan 2023 08:00:00 GMT
• Century, Elevation are latest to follow layoff, pipeline cull route as Nabriva winds down Fierce Biotech Fri, 06 Jan 2023 08:00:00 GMT
• an antibiotics biotech begins wind-down, lays off nearly all workers Endpoints News Fri, 06 Jan 2023 08:00:00 GMT
• nabriva to focus on preserving cash to fund wind down of operations TipRanks Fri, 06 Jan 2023 08:00:00 GMT
• century, elevation latest to cut assets, staff; nabriva winds down Fierce Biotech Fri, 06 Jan 2023 08:00:00 GMT
• nabriva (nbrv) posts positive data from cystic fibrosis study Nasdaq Tue, 29 Nov 2022 08:00:00 GMT
• Nabriva's antibiotic shows promise as a potential cystic fibrosis treatment The Business Journals Mon, 28 Nov 2022 08:00:00 GMT
• nabriva therapeutics announces positive topline results from phase 1 trial of xenleta® (lefamulin) in adult patients with cystic f... Stock Titan Mon, 28 Nov 2022 08:00:00 GMT
• nabriva adds 9% on positive results from study of xenleta in cystic fibrosis Nasdaq Mon, 28 Nov 2022 08:00:00 GMT
• nabriva announces positive results from phase 1 trial of lefamulin in cystic fibrosis; stock up Nasdaq Mon, 28 Nov 2022 08:00:00 GMT
• Nabriva halts R&D, lays off 40% of staff in commercial-focused pivot for survival Fierce Biotech Fri, 11 Nov 2022 08:00:00 GMT
• nabriva despide al 40% del personal y detiene su apuesta por la investigación ConSalud.es Fri, 11 Nov 2022 08:00:00 GMT
• nabriva therapeutics pivoting strategic focus reports third quarter financial results and provides corporate update GlobeNewswire Thu, 10 Nov 2022 08:00:00 GMT
• montgomery county biopharmaceutical firm reducing workforce by 40% The Business Journals Thu, 10 Nov 2022 08:00:00 GMT
• fort washington-based nabriva to cut workforce 40%, explore 'strategic alternatives' - philadelphia business journal The Business Journals Thu, 10 Nov 2022 08:00:00 GMT
• nabriva therapeutics describes new 12-epi-mutilin compounds to treat bacterial infections BioWorld MedTech Wed, 09 Nov 2022 08:00:00 GMT
• nabriva therapeutics to report third quarter 2022 financial GlobeNewswire Mon, 07 Nov 2022 08:00:00 GMT
• the global infectious disease diagnostics market to register ... GlobeNewswire Tue, 01 Nov 2022 07:00:00 GMT
• the 1001 imploded stocks of 2022 (down 80% or more)… so far WOLF STREET Mon, 17 Oct 2022 07:00:00 GMT
• community-acquired bacterial pneumonia (cabp) treatment drugs market to reach us$ 2075.34 million by 2027 ... Medgadget Mon, 10 Oct 2022 07:00:00 GMT
• the global sepsis diagnostics market to register growth at a ... GlobeNewswire Thu, 06 Oct 2022 07:00:00 GMT
• what is going on with nabriva therapeutics (nbrv) stock today? InvestorPlace Fri, 16 Sep 2022 07:00:00 GMT
• why is esports entertainment (gmbl) stock down 45% today? Markets Insider Fri, 16 Sep 2022 07:00:00 GMT
• analyzing the slowdown in pharma's digital ad-spend growth MM+M Online Fri, 16 Sep 2022 07:00:00 GMT
• nabriva therapeutics announces date of 1-for-25 reverse stock split GlobeNewswire Thu, 15 Sep 2022 07:00:00 GMT
• all you need to know about nabriva therapeutics ag (nbrv) rating upgrade to buy Yahoo Finance Wed, 14 Sep 2022 07:00:00 GMT
• analyst sees 60% upside for nabriva (nbrv) following merck deal - tipranks.com TipRanks Sun, 21 Aug 2022 22:23:00 GMT
• lab notes: adaptimmune to expand manufacturing at navy yard ... The Business Journals Fri, 12 Aug 2022 07:00:00 GMT
• nabriva therapeutics reports second quarter 2022 financial results and provides a corporate update Yahoo Finance Wed, 03 Aug 2022 07:00:00 GMT
• isaric-covid-19 dataset: a prospective, standardized, global ... Nature.com Sat, 30 Jul 2022 07:00:00 GMT
• nabriva therapeutics to report second quarter 2022 financial results and recent corporate highlights on august 3 ... GlobeNewswire Wed, 20 Jul 2022 07:00:00 GMT
• nabriva therapeutics expands xenleta® (lefamulin) presence with exclusive agreement with er-kim pharmaceuticals Yahoo News Mon, 18 Jul 2022 07:00:00 GMT
• as big pharma loses interest in new antibiotics, infections are only ... Modern Healthcare Fri, 15 Jul 2022 07:00:00 GMT
• nabriva therapeutics plc : notice of delisting or failure to ... Marketscreener.com Wed, 06 Jul 2022 07:00:00 GMT
• antibiotics safe for some outpatients with acute appendicitis Medpage Today Tue, 05 Jul 2022 07:00:00 GMT
• another pneumonia antibiotic is close to treating patients Labiotech.eu Fri, 24 Jun 2022 07:00:00 GMT
• nabriva therapeutics gets fda green light for pneumonia antibiotic Labiotech.eu Fri, 24 Jun 2022 07:00:00 GMT
• nabriva therapeutics' pneumonia antibiotic gets positive phase iii results Labiotech.eu Fri, 24 Jun 2022 07:00:00 GMT
• a better understanding of pain relief could bring us new drugs Labiotech.eu Fri, 24 Jun 2022 07:00:00 GMT
• austrian biotech scores a phase iii win in the fight against antibiotic resistance Labiotech.eu Thu, 23 Jun 2022 07:00:00 GMT
• multicenter evaluation of the novel etest fosfomycin for ... American Society for Microbiology Thu, 23 Jun 2022 07:00:00 GMT
• nabriva therapeutics to present at the h.c. wainwright global investment conference Barchart.com Fri, 13 May 2022 07:00:00 GMT
• nabriva therapeutics plc (nbrv) ceo ted schroeder on q1 2022 results - earnings call transcript Seeking Alpha Sun, 08 May 2022 07:00:00 GMT
• lab notes: endo acquires 6 product candidates for $35m; nikang signs deal worth up to $218m The Business Journals Fri, 06 May 2022 07:00:00 GMT
• philadelphia-area life sciences news: updates from endo, nikang, galera, marinus and more - philadelphia business ... The Business Journals Fri, 06 May 2022 07:00:00 GMT
• nabriva therapeutics reports first quarter 2022 financial results and provides a corporate update Yahoo Finance Thu, 05 May 2022 07:00:00 GMT
• nabriva therapeutics to report first quarter 2022 financial results and recent corporate highlights on may 5, 2022 Yahoo Finance Mon, 02 May 2022 07:00:00 GMT
• pharma's digital product launches plagued by single-digit success ... MM+M Online Fri, 29 Apr 2022 07:00:00 GMT
Nabriva Therapeutics plc(NASDAQ:NBRV) 